Kedrion Biopharma
Paloma De Miguel has extensive work experience in the field of regulatory affairs, particularly within the pharmaceutical industry. Starting in 1989, they held multiple roles at Baxter Healthcare, including Vice President of Regulatory Affairs - International and Vice President of Regulatory Affairs EMEA. Paloma also served as Vice President of Global Regulatory Affairs Bioscience and Director of Regulatory Affairs Europe-Hyland Immuno during their time at Baxter Healthcare. In 2015, they transitioned to Baxalta, where they served as Vice President of Regulatory Affairs International. In 2017, Paloma founded Sacmis RA and worked as a Regulatory Affairs Consultant until 2018. Currently, they are the Chief Medical and Regulatory Affairs Officer at Kedrion Biopharma, where they previously served as the Senior Vice President of Global Regulatory Affairs.
Paloma De Miguel has attended the University of Valencia and pursued a PhD in Biology. No specific start or end years for these education experiences are provided.
This person is not in any offices
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.